SCHEMBL22552787

SCHEMBL22552787

COC(C)(C)/C=C/CCCCC(O)C(C)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GMNN O75496 1/20 0.34
USP2 O75604 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
APEX1 P27695 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ABCB1 P08183 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
ACLY P53396 1/20 0.33
FAAH O00519 1/20 0.32
FFAR1 O14842 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22552785 1.00 GMNN (0.34) GMNNUSP2CYP1A2POLBCYP3A4
SCHEMBL20826003 0.84 ACE2 (0.39) GMNNUSP2CYP1A2POLBCYP3A4
SCHEMBL22552698 0.83 GMNN (0.36) GMNNUSP2CYP1A2POLBCYP3A4
SCHEMBL22552701 0.83 GMNN (0.36) GMNNUSP2CYP1A2POLBCYP3A4
SCHEMBL22552845 0.74 ALDH1A1 (0.44) USP2CYP3A4RECQLTRPV1ALDH1A1
SCHEMBL22552847 0.74 ALDH1A1 (0.44) USP2CYP3A4RECQLTRPV1ALDH1A1
SCHEMBL22552604 0.74 ACACB (0.41) CYP3A4RECQLHSD17B10ABCB1TRPV1
SCHEMBL22552603 0.74 ACACB (0.41) CYP3A4RECQLHSD17B10ABCB1TRPV1
SCHEMBL10368812 0.73 MAPT (0.47) USP2CYP3A4RECQLTRPV1ALDH1A1
SCHEMBL22552743 0.68 BLM (0.45) BLMABCB1TRPV1MAPTFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681875-B1 CYCLIC PEPTIDE ANTIBIOTICS HOFFMANN LA ROCHE (CH) 2026-01-14 EP disclosed
US-11279735-B2 Cyclic peptide antibiotics GENENTECH, INC. (US) 2022-03-22 US disclosed
US-20200331968-A1 CYCLIC PEPTIDE ANTIBIOTICS GENENTECH, INC. (US) 2020-10-22 US disclosed
CN-111148739-A Cyclopeptide antibiotics 豪夫迈·罗氏有限公司 2020-05-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331968-A1 CYCLIC PEPTIDE ANTIBIOTICS NPPA, LNPEP, CLPP GMNN 4144/4885USP2 1163/4885CYP1A2 4508/4885
US-11279735-B2 Cyclic peptide antibiotics NPPA, LNPEP, CLPP GMNN 4144/4885USP2 1163/4885CYP1A2 4508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.